Potential and limitations of LC-MS/MS based multi- mycotoxin...

47
AOAC/ASFILAB Workshop Paris, November 2009 Potential and limitations of LC-MS/MS based multi- mycotoxin analysis Michael Sulyok, Rainer Schuhmacher, Rudolf Krska

Transcript of Potential and limitations of LC-MS/MS based multi- mycotoxin...

Page 1: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Potential and limitations of LC-MS/MS based multi-

mycotoxin analysis

Michael Sulyok, Rainer Schuhmacher, Rudolf Krska

Page 2: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Outline

Introduction – Mycotoxins

Setting up an LC-MS/MS multi-mycotoxin method

Pitfalls and counteractive measures

Benefits

Page 3: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

MycotoxinsDefinition• Low molecular weight-secondary metabolites produced by molds

(plants; processed food; damp buildings)

Function• „Chemical weapons“ against hosts and competitors

Formation• Fusarium sp., Aspergillus sp., Penicillium sp., Alternaria sp.

• Usually synthesis of a group of compounds

Occurrence

25 % of all cereals are contaminated with mycotoxins

=> most important chronic dietary risk factor (> synthetic

contaminants, pesticides, food additves, plant toxins)

Economic losses: 109 $ / a in US

FAO

Page 4: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Analytes – Structures (I)

OH

O

CH3

H

O

OOH

Zearalenon

O

H

CH2OH

OH

CH3

OH

H

H

H

HO

O

CH3

DON

Trichothecenes

NIV, DON, FUS-X, 3ADON, DAS, HT2, T2,

DON-3-Glucoside, Deepoxy-DON, Verrucarol, Neosolaniol,

Monoacteoxyscirpenol, Verrucarin

gastrointresinaldisturbance, immunos., inhibition of proteinsynthesis

Zearalenone

derivatives

ZON, ZOLs,

ZON-Sulfat, ZON-Glucoside

xenoestrogen

O O

O

O O

OCH3

Aflatoxins

Aflatoxin B1, B2, G1, G2

potent carcinogen; hepato-toxic (2004: 350 death

cases in Kenya)

Aflatoxin B1

O

CH

2

CH N

OOOH

Cl

O

O

HH

CH3

Ochratoxins

Ochratoxin A, B, α

nephrotoxin; teratogen,cancerogen,

immunosuppr.Ochratoxin A

Page 5: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Analytes – Structures (II)

ON

O

N

NO

O

OO

O O

O

Enniatins (5)

Beauvericin

Enniatin A, A1, B, B1

APOLAR

cationophor, cytotoxic

Beauvericin

O

O

[COOH][COOH]

O

O [COOH]

[COOH]

CH3

CH3

OH

OH

CH3

OH

NH2

Fumonisins (3)

Fumonisin FB1, FB2, hydrolyzed FB1

HYDROPHILIC, ACIDIC

cancerogen; interfereswith sphingolipid

synthesis

FB1

Ergot alkaloids (4)

Ergotamin, Ergocornin, Ergovalin, Dihydroergosin

POLAR, BASIC

Ergotism

N

NH

CH3

CH3

H

H

AgroclavinOH O

OMoniliformin

pKa: 1.7

cardiotoxic

Page 6: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Multi-analyte methods for mycotoxins:

The reasons...

• 300-400 substances recognized as mycotoxins

13 addressed by legislation

approx. 25 covered by methods described in the literature

• Screening of wide range of analytes necessary for evaluation of

synergistic effects of different mycotoxins (McKean et al., J. Appl.

Toxicol. 2006, 26, 139)

• Unified method for various analytical purposes

Reference method for development of rapid tests

Characterization of standards

Chemotaxonomy – Determination of production strains, metabolite pattern in real-world samples

Page 7: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

...and the challenges

range of relevant concentrationsEU: 2 µg / kg (AFB1) –

1500 µg / kg (DON)

chemical diversity of analytes

ionic ⇔ apolar

acidic ⇔ basic

various matrices

(wheat, maize, cereals, wine, milk, …)

sensitivity, linearity selectivity

general detection principle minimum samplepreparation

Page 8: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

...and the challenges

range of relevant concentrationsEU: 2 µg / kg (AFB1) –

1500 µg / kg (DON)

chemical diversity of analytes

ionic ⇔ apolar

acidic ⇔ basic

various matrices

(wheat, maize, cereals, wine, milk, …)

sensitivity, linearity selectivity

general detection principle minimum samplepreparation

HPLC / MS-MS analysis of crude extracts

is thisfeasible??

signalsuppression?!

Page 9: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Outline

Introduction – Mycotoxins

Setting up an LC-MS/MS multi-mycotoxin method

Pitfalls and counteractive measures

Benefits

Page 10: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

LC-MS/MS – Instrumentation

HPLC: Agilent 1100; Gemini C18

MeOH/H2O gradient, 1% HAc, 5mM NH4Ac

MS: QTrap 4000 MS/MS (equipped withTurboIon Source)

Ion path

Collision cell (N2) ExitSkimmer

Orifice

Q0 Q1 Q2 Q3

From: James W. Hager, MDS Sciex,

ASMS 2002

Ions

Q3 = Trap

Multiplier

Quantification in the SRM-mode (triple quad configuration):

Sequential scanning of fragmentation reactions (2 per analyte, 100ms each); parameter optimization via direct infusion of the analytes

Confirmation of positive results by Enhanced Product Ion scans (trapconfiguration)

Page 11: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Optimization of HPLC conditions

2 4 6 8 12 14 16 18 20Time, min

5000

1.0e4

1.5e4

Intensity, cps

FB1

HFB1

FB2

OHNH

2

OH OH

OH

OH

O

O

O

O

CH3

CH3

OH

OH

CH3

OH

NH2

HOOC

COOH

COOH

COOH

� Acidic eluent for fumonisins necessary

Elution of fumonisins at neutral pH

Page 12: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Elution of fumonisins at pH 3

13.24

2 4 6 8 12 14 16 18 20 Time, min

1e4

2e4

3e4

4e4

Intensity, cps

HFB1

FB1

FB2

� Gemini C18-column

�Linear gradient from

10% to 97% MeOH

�acidified eluent

(1% HAc besides

5mM NH4Ac)

Final HPLC conditions

Page 13: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Separation of ergotamine epimers

11.05 11.10 11.15 11.20 11.25 11.30 11.35 11.40 11.45 11.50 11.55 11.60 11.65 11.70 11.75 11.80 11.85Time, min

0.0

1000.0

2000.0

3000.0

4000.0

5000.0

6000.0

7000.0

8000.0

9000.0

1.0e4

1.1e4

1.2e4

1.3e4

1.4e4

1.5e4

1.6e4

1.7e4

1.8e4

1.9e4

2.0e4

2.1e4

2.2e4

2.3e4

2.4e4

Inte

nsity

, cp

s

11.57

11.71

Quantifier SRM

Qualifier SRM (x5)

Separation of epimersincomplete under acidicconditions; alkalineconditions would be

preferable (∆rt = 2.6 min)

ergotamine

ergotaminine

Page 14: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 20092 4 6 8 10 12 14 16 18 20

Time, min0.0

5.0e4

1.0e5

1.5e5

2.0e5

2.5e5

3.0e5

3.5e5

4.0e5

4.5e5

5.0e5

5.5e5

6.0e5

6.5e5

7.0e5

7.5e5

8.0e5

Inte

nsity

, cps

15.16

17.30

10.927.98

15.416.70

Scheduled MRM vs. periods : A useful software upgrade

2 4 6 8 10 12 14 16 18 20Time, min

0.0

5.0e4

1.0e5

1.5e5

2.0e5

2.5e5

3.0e5

3.5e5

4.0e5

4.5e5

5.0e5

Inte

nsity

, cps

12.16

9.207.43

9.32 12.5613.37

8.62

15.86

8.0611.39

15.029.506.13

16.08

Positive run 1

Positive run 2

Periods:

SRMs of defined setsof analytes arescanned during fixedperiods

• demands extremelystable retention times

• difficulties to setperiod limits in multi-analyte methods

(max. 100)

• a lot of junk data is

produced (waste of acquisition time)

Page 15: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Merged ESI (+) Scheduled SRM chromatogramof 125 analytes

2 4 6 8 10 12 14 16 18 20Time, min

0.0

2.0e4

4.0e4

6.0e4

8.0e4

1.0e5

1.2e5

1.4e5

1.6e5

1.8e5

2.0e5

2.2e5

2.4e5

2.6e5

Inte

nsity

, cps

3.23

• Separate time window for each analyte (tR ± 0.4 min)

⇒ minor retention shiftsare irrelevant

⇒ optimum use of acquisition time (SRM dwell times generateddynamically)

⇒ more analytes can beincluded in a single run(300-1000); 2 runs/sample

instead of 3

Page 16: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Choice of solvent for extraction of wheat

Best compromise: Low water content, low pH ⇒ ACN/H2O/HAc 79/20/1(results similar for maize)„acidified acetonitril/water mixtures are the default method for multi-analyte

analysis..“ (Mol et al., Anal. Chem. 2008, 9450-9458)

0

20

40

60

80

100

120

HT2

-Toxi

n

Niv

alen

ol

Zeara

lenon

Och

rato

xin

A

Afla

toxi

n B1

Ergoc

ornin

Monili

form

inFum

onisi

n B2

ex

tra

cti

on

eff

icie

nc

y (

%)

MeOH/H2O 1/1 ACN/H2O 84/16 ACN/H2O/HAc 79/20/1

(n=3);

0.5g sample +

2ml solvent;

Extract

diluted 1:10

Page 17: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Sample preparation scheme

Grinding

Extraction (90 min)

5g sample +

20mL ACN+H2O+HAc

79+20+1 v+v+v

(optimized!)

Dilution (1+1) withACN/H2O/HAc 20/79/1

Analysis 2x21 mins.

(pos. / neg. mode)

Reduced time and material consumption!

Page 18: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Outline

Introduction – Mycotoxins

Setting up an LC-MS/MS multi-mycotoxin method

Pitfalls and counteractive measures

Benefits

Page 19: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Matrix effects – the foe of LC-MS/MS

• Not to be exchanged with interference – effect is invisible

• Effect caused by co-eluting matrix constituents

competition for electrical charge

modification of surface tension of ESI droplet

• Extent is both matrix- and analyte-dependent

• May effect only small sections of chromatogramm

⇒ Use of non-coeluting internal standards insufficient; closely elutinganalogues with similar structure (zearalanon vs. zearalenon) may beacceptable

Approaches: Standard addition

Matrix matched calibration

Isotopically labelled internal standards

Page 20: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Extraction efficiency ⇔⇔⇔⇔ matrix effects (1)

13.7 13.8 13.9 14.0 14.1 14.2 14.3 14.4 14.5 14.6 14.7 14.8 14.9 15.0 15.1 15.2 15.3 15.4 15.5Time, min

0

200

400

600

800

1000

1200

1400

1600

1800

2000

2200

2400

2600

2800

3000

3200

3400

3600

3800

4000

4200

4378

Inte

nsity

, cps

14.02

14.03

liquid standard

Peak area: 29000

spikedbreadcrumbs

Peak area: 22700

O

O

OH

OH

RAlternariol R=OH

Alternariolmethylether R=OCH3

⇒ Apparent recovery: ca.

80%

Signal suppression or

bad extraction efficiency?

Page 21: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Extraction efficiency ⇔⇔⇔⇔ matrix effects (2)

13.7 13.8 13.9 14.0 14.1 14.2 14.3 14.4 14.5 14.6 14.7 14.8 14.9 15.0 15.1 15.2 15.3 15.4 15.5Time, min

0

200

400

600

800

1000

1200

1400

1600

1800

2000

2200

2400

2600

2800

3000

3200

3400

3600

3800

4000

4200

4378

Inte

nsity

, cps

14.02

14.03

14.01

liquid standard

Peak area: 29000

spikedbreadcrumbs

Peak area: 22700

spiked breadcrumbextract

Peak area: 22900

O

O

OH

OH

RAlternariol R=OH

Alternariolmethylether R=OCH3

⇒ Extraction efficiency not

affected

Signal suppression (ca

20%)

Page 22: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

169.000

14.0 14.1 14.2 14.3 14.4 14.5 14.6 14.7 14.8 14.9 15.0 15.1 15.2

Time, min

0.0

1000.0

5000.0

1.0e4

1.2e4

1.4e4

1.6e4

1.8e4

2.0e4

2.2e4

Inten

sity, cps

14.57

liquid standard

100 µg/kg

Blank breadcrumbs

spiked with 100 µg/kgCitrinin

O

O

O OH

OH

51.00014.6

Blank breadcrumbs

Raw extract spiked

164.000

⇒ No signal suppression

Extraction efficiency ca. 30%

Extraction efficiency ⇔⇔⇔⇔ matrix effects (3)

Page 23: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Method Validation

A: liquid standard; 10

concentration levels, 4 injections each

B: blank extract;

spiked at 10 concentration levels

C: spiked samples;10

levels, each in triplicate; extractionand dilution

Calibration functions(1/x weighted)

Comparison of slopes

C / A: apparent recovery

B / A: signal suppression

/ enhancement

C / B: recovery of the

extraction step

Process standard deviation

Precision

Trueness

Page 24: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Validation of maize

75124932.2Moniliformin

93-10778-108; 141Z4G79-101; 141Z4G0.5-0.7;3Z4SZearalenons

86-10396-100; 83OTαααα98-100; 71OTαααα0.4-1.2Ochratoxins

57-75101-104;63 HFB147-700.4-1.4Fumonisins

86-103101-10994-1060.6-1.9Beau + Ennis

86-11027-6230-620.6-1.3Ergot alkal.

95-11048-62; 18AFB149-68; 17AFB11.3-2.8Aflatoxins

66(NIV, D3G) - 9992-110; 157D3G93-106; 74NIV0.3-1.3B-Trichos

97-10873-9276-980.2-0.8A-Trichos

Recovery of extraction (%)

Signal supp. / enh. (%)

Apparentrecovery (%)

ProcessSTDEV (%)

Analyte class

• matrix effects for Aflas, Ergots and some other compounds

• incomplete extraction of polar analytes

• excellent reproducibility and linearity ⇒⇒⇒⇒ matrix calibration to correct

for matrix effects (variation between individual samples?!)

Page 25: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Validation of rice

51113582.2Moniliformin

83 - 10599 - 10989 - 1100.8-2.6Zearalenons

95 - 97; 62 OTαααα99 - 11496 - 98; 71 OTαααα0.8-1.9Ochratoxins

74 - 85100 - 10774 - 881.2-2.7Fumonisins

1011001012.0Beauvericin

94 - 10695 - 10693 - 1121.6-3.2Ergot alkal.

93 - 10982 - 10194 - 983.1-5.1Aflatoxins

89 - 10197 - 10688 - 1050.9-4.0B-Trichos

96 - 10499 - 10598 - 1050.5-0.7;A-Trichos

Recovery of extraction (%)

Signal suppr. / enh. (%)

Apparentrecovery (%)

Processstdev (%)

Analyte class

Process st.dev. < 6.0% in spelt and barley (Z4S: 12%)

Signal suppr./enh.: spelt: Aflas 75-91%, Ergots 70-99%

barley: Aflas 47-75 %, Ergots 66-89%, ZONs: 52-69%

⇒⇒⇒⇒ Method transferable to other grain matrices, matrix-MATCHED calibration

Page 26: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Variation of signal intensities within a given matrix

Maize: Variation of analytical signal acceptably low (exception: D3G 32%)

Rice: Dramatically decreased signal intensities for some analytes in red rice(compared to peeled and brown rice)

⇒⇒⇒⇒ For a quantitative analysis, the model matrix must match the samples as close as possible!!!

Blank extracts of 3

individual samplesspiked at 5 concentration levels

0

5

10

15

20

25

30

35

A-

Trichos

B-

Trichos

Aflas Ergots Ennis Fumos Ochras ZONs Moni

RS

D (

%)

maize

rice

Page 27: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Analysis of DON in reference materialswith and without 13C15-DON

0

100

200

300

400

500

600

700

1 2

DO

N [

µg

/kg

]

CRM maize CRM wheat

(certified) target

concentrations13C labeled internalstandards compensatematrix effects even on less robust instruments(QTrap 2000)

Approach applicable to

regulated toxins, but not for multi-mycotoxin analysis(costs, availabilitiy)

Page 28: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

ESI-MS/MS-Parameters

Contributionof Dr. Robert Köppen,

BAM, Berlin

Page 29: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Confirmation of positive results in HPLC-MS/MS according to 2002/657/EC

• Identification points: 1 IP parent ion, 1.5 IP product ion

• 3 IPs required for mycotoxins (group B of Annex I in 96/23/EC)

• 4 IPs required for banned substances

• 2 SRM transitions per analyte

• Retention time must agree with authentic standard (± 2.5% rel.)

• Intensity ratio of 2 SRMs must agree with authentic standard (± 20% rel.)

• Complied by most methods, but...

...is this sufficient?!

Page 30: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Roridin A in citrus fruits?

13.65 13.70 13.75 13.80 13.85 13.90 13.95 14.00 14.05 14.10 14.15Time, min

0

50

100

150

200

250

300

350

400

450

500

550

600

650

700

750

800

850

900

950

1000

1050

1100

1150

1200

1250

1300

Inte

nsity

, cps

13.89

SRM 550.4/249.2

SRM 550.4/231.2

Comparison to standard

∆rt: 0.09 min (0.7%)macrocyclictrichothecene produced by Myrothecium roridum

and Myrothecium

verrucaria

O

O

O

OO

O

O

OH

OH

H H

H

Page 31: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Comparison of product ion spectra of the precursour ion m/z=550.4

Inte

nsity

, cp

sIn

tensity

, cp

s

58.wiff (Turbo Spray) Max. 1,7e5 cps.

100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600

m/z , amu

1,0e4

2,0e4

3,0e4

4,0e4

5,0e4

6,0e4

7,0e4

8,0e4

9,0e4

1,0e5

1,1e5

1,2e5

1,3e5

1,4e5

1,5e5

1,6e5

1,7e5249,2

133,1

231,2

550,4

333,2

137,1

533,3

213,2203,2 385,3185,2247,1

161,2403,2

195,2159,1131,1

201,1119,1 469,0

337,3219,2147,1187,1175,3 344,8 490,1 515,2

379,2105,3 331,1207,2 387,6

100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600

m/z , amu

249,2133,1

231,2550,4

333,2

137,1533,3

213,2203,2 385,3185,2247,1

161,2403,2

195,2159,1131,1

201,1119,1 469,0

337,3219,2147,1187,1175,3 344,8 490,1 515,2

379,2105,3 331,1207,2 387,6

reference

standard

substanceeluting at 14.05 min in orange

369,2

533,3

411,2

550,3

515,3

455,3

413,3393,2

473,3437,2367,3

341,2

429,2161,0 409,2351,2

385,3395,3

431,3469,2375,1365,2187,1 315,2295,2 333,2261,2 383,2245,2231,1

133,0 401,2373,0 487,3159,1 497,2197,1 269,2287,2265,3 329,2247,1177,2 445,4217,2 453,4381,3119,2137,0 534,2207,1 489,5361,3169,0 425,2 509,4

+EPI (550,40) CE (25): 14,024 to 14,128 min from Sample 1 (z1_056) of 56.wiff (Turbo Spray) Max. 1,6e5 cps.

100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600m/z, amu

1,0e4

2,0e4

3,0e4

4,0e4

5,0e4

6,0e4

7,0e4

8,0e4

9,0e4

1,0e5

1,1e5

1,2e5

1,3e5

1,4e5

1,5e5

1,6e5

+EPI (550,40) CE (25): 14,024 to 14,128 min from Sample 1 (z1_056) of 56.wiff (Turbo Spray) Max. 1,6e5 cps.

100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500 520 540 560 580 600m/z, amu

1,0e4

2,0e4

3,0e4

4,0e4

5,0e4

6,0e4

7,0e4

8,0e4

9,0e4

1,0e5

1,1e5

1,2e5

1,3e5

1,4e5

1,5e5

1,6e5369,2

533,3

411,2

550,3

515,3

455,3

413,3393,2

473,3437,2367,3

341,2

429,2161,0 409,2351,2

385,3395,3

431,3469,2375,1365,2187,1 315,2295,2 333,2 383,2249,2231,1

133,0 401,2373,0 487,3159,1 497,2197,1 269,2287,2265,3 329,2247,1177,2 445,4217,2 453,4381,3119,2137,0 534,2207,1 489,5361,3169,0 425,2 509,4

substance eluting

at 14.05 min in citrus fruits

⇒ Two SRM transitions may be still insufficient for confirmation of identity!

Page 32: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Outline

Introduction – Mycotoxins

Setting up an LC-MS/MS multi-mycotoxin method

Pitfalls and counteractive measures

Benefits

Page 33: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of emerging mycotoxins

• 49 different analytes identified in the 247 sub-samples

Page 34: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of emerging mycotoxins

• 49 different analytes identified in the 247 sub-samples

• regulated toxins: DON 21st in ranking

Page 35: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of emerging mycotoxins

• 49 different analytes identified in the 247 sub-samples

• regulated toxins: DON 21st in ranking

Page 36: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of emerging mycotoxins

• 49 different analytes identified in the 247 sub-samples

• regulated toxins: DON 21st in ranking

Page 37: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of emerging mycotoxins

• 49 different analytes identified in the 247 sub-samples

• regulated toxins: DON 21st in ranking

Page 38: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of „unexpected“ analyte/matrix combinations

TIC of +EPI (329.10) CE (45) CES (20): from Sample 1 (epiafm1_peanutcont8_008) of 8.wiff (Turbo Spray) Max. 7.1e6 cps.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20Time, min

0.0

5.0e5

1.0e6

1.5e6

2.0e6

2.5e6

3.0e6

3.5e6

4.0e6

4.5e6

5.0e6

5.5e6

6.0e6

6.5e6

7.0e6

Inte

nsity

, cps

15.28

15.46

12.80

16.36

17.96

14.4314.21

11.509.52 12.21

4.029.96

8.18

„milk toxin“ in peanuts???

EPI scan for Aflatoxin M1 in contaminated peanut

Page 39: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Identification of „unexpected“ analyte/matrix combinations

+EPI (329.10) CE (45) CES (20): 11.449 to 11.551 min from Sample 1 (epiafm1_peanutcont8_008) of 8.wiff (Turbo Spray)Max. 1.2e5 cps.

100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350m/z, amu

5000.00

1.00e4

1.50e4

2.00e4

2.50e4

3.00e4

3.50e4

4.00e4

4.50e4

5.00e4

5.50e4

6.00e4

6.50e4

7.00e4

7.50e4

8.00e4

8.50e4

9.00e4

9.50e4

1.00e5

1.05e5

1.10e5

1.15e5

1.19e5

Inte

nsity

, cps

329.2

273.2

135.1259.2247.1229.1153.2

301.1 315.0181.2 283.2117.1 203.0 328.4213.1111.0 332.8

100 120 140 160 180 200 220 240 260 280 300 320 340m/z, amu

329.1

273.1

229.1 259.1247.1 301.1

153.2 181.2 283.2

Presence of Aflatoxin M1 in

peanut confirmed!

Isolated Aspergillus

flavus strain

produces AFM1 (1/100 of AFB1)

EPI-spectrum of

referencestandard

Page 40: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

XIC of +MRM (298 pairs): 143.0/113.2 amu Expected RT: 3.4 ID: Kojic acid from Sample 1 (hazelnut6_016) of 14.wiff (Turbo Spray)

1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0Time, min

0

500

1000

1500

2000

2500

3000

3500

4000

4500

5000

5500

6000

6291

Inte

nsity

, cps

3.19

3.56 18.272.95

„Self-validation“

AFB1

AFG1

Page 41: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

XIC of +MRM (298 pairs): 143.0/113.2 amu Expected RT: 3.4 ID: Kojic acid from Sample 1 (hazelnut6_016) of 14.wiff (Turbo Spray)

1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0Time, min

0

500

1000

1500

2000

2500

3000

3500

4000

4500

5000

5500

6000

6291

Inte

nsity

, cps

3.19

3.56 18.272.95

„Self-validation“

AFB1

AFG1Kojic acid

Aspergillus flavus

Page 42: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

XIC of -MRM (100 pairs): 118.0/46.0 amu Expected RT: 3.3 ID: 3-NPA from Sample 1 (hazelnut6_016) of 48.wiff (Turbo Spray)

1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0Time, min

0.0

5000.0

1.0e4

1.5e4

2.0e4

2.5e4

3.0e4

3.5e4

4.0e4

4.5e4

5.0e4

5.5e4

6.0e4

6.5e4

7.0e4

7.5e4

8.0e4

Inte

nsity

, cps

3.11

„Self-validation“

3-NPA (A.

flavus)

Alternariol

Alternariol-methylether

Page 43: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

XIC of -MRM (100 pairs): 118.0/46.0 amu Expected RT: 3.3 ID: 3-NPA from Sample 1 (hazelnut6_016) of 48.wiff (Turbo Spray)

1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0Time, min

0.0

5000.0

1.0e4

1.5e4

2.0e4

2.5e4

3.0e4

3.5e4

4.0e4

4.5e4

5.0e4

5.5e4

6.0e4

6.5e4

7.0e4

7.5e4

8.0e4

Inte

nsity

, cps

3.11

„Self-validation“

3-NPA (A.

flavus)

Tenuazonic

acid

Alternariol

Alternariol-methylether

MacrosporinA

Alternaria

sp.!

Page 44: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Consistency of metabolite production

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19Time, min

1.0e5

2.0e5

4.0e5

5.0e5

Inte

nsity

, cp

s

14.07

15.8011.17

13.70 15.989.17.68

7.68 Chanoclavin

5 µg/kg

9.1Festuclavin

2 µg/kg

11.17Meleagrin2600 µg/kg

14.07 Fumonisin B233000 µg/kg

15.80 Enniatin B25 µg/kg13.70

Mycophenolicacid 760 µg/kg

ESI(-)-MS/MS:

Emodin 2500 µg/kg

Alternariol methylether

7 µg/kg

Page 45: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Fumonisin B2 in dark bread

100 150 200 250 300 350 400 450 500 550 600 650 700 750m/z, amu

2,0e6

4,0e6

6,0e6

8,0e6

Inte

nsity

, cp

s

336,4

318,4

354,4

512,3688,5

706,5670,3530,4

494,6149,2 372,4238,3 548,3

100 150 200 250 300 350 400 450 500 550 600 650 700 750m/z, amu

336,3

318,4

354,4

512,3 706,5688,4

494,3 530,5372,3301,3 670,3

548,6

Standard

100 150 200 250 300 350 400 450 500 550 600 650 700 750m/z, amu

2,0e6

4,0e6

6,0e6

8,0e6

Inte

nsity

, cp

s

336,4

318,4

354,4

512,3688,5

706,5670,3530,4

494,6149,2 372,4238,3 548,3

100 150 200 250 300 350 400 450 500 550 600 650 700 750m/z, amu

336,3

318,4

354,4

512,3 706,5688,4

494,3 530,5372,3301,3 670,3

548,6

Standard

Specific production of FB2 by Aspergillus niger

(Frisvad et al. 2007)

EPI spectra of m/z=706.3 at 14.14 min

black spotof moldydark bread

⇒ confirmation of occurrence of unusualtoxin patterns (no FB1 or

FB3)

Page 46: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.0 15.5 16.0 16.5 17.0 17.5 18.0Time, min

0.0

2000.0

4000.0

6000.0

8000.0

1.0e4

1.2e4

1.4e4

1.6e4

1.8e4

2.0e4

2.2e4

2.4e4

2.6e4

2.8e4

3.0e4

3.2e4

3.4e4

3.6e4

3.8e4

4.0e4

4.2e4

4.4e4

4.6e4

4.8e4

4.9e4

Inte

nsity

, cps

Isofumigaclavine

Fumigaclavine

Penicillic acid

Festuclavine

Pentoxyfylline

Viridicatin

Enniatins

Alamethicin F30

Puromycin

Myriocin

Nonactin

Monactin

Dinactin

Valinomycin

Multi-metabolite analysis in settled dust from a waste-management plant

⇒⇒⇒⇒ Simplicity of method allowssimple transfer

to othermatrices and metabolites

Page 47: Potential and limitations of LC-MS/MS based multi- mycotoxin analysisaoaceurope.com/2009p/Sulyok.pdf · 2018-02-12 · Potential and limitations of LC-MS/MS based multi-mycotoxin

AOAC/ASFILAB Workshop Paris, November 2009

Conclusions

Pros and Cons of LC-MS/MS multi-mycotoxin analysis:

Use in routine analysis is limited by matrix effects⇒⇒⇒⇒ fast screening analysis (followed by dedicated quantitative method)

⇒⇒⇒⇒ 13C labelled internal standards may overcome this problem (costs?)

Method is a valuable tool at the cutting edge of science⇒⇒⇒⇒ gives a more comprehensive picture of human exposure to toxicfungal metabolites (emerging mycotoxins, unusual toxin / matrixcombinations, including non-food matrices)

⇒⇒⇒⇒ chemotaxonomy – metabolite production in real world samples

⇒⇒⇒⇒ method is flexibe enough to include more analytes and matricese.g. study co-exposure to fungi and bacteria at the metabolic level